期刊文献+

帕金森病运动症状与并发症评估的研究进展 被引量:1

下载PDF
导出
摘要 帕金森病(Parkinson disease,PD)是一种病因不明的渐进性神经退行性疾病,是中老年人常见的运动障碍性疾病。据报道,帕金森病平均发病年龄60岁,从诊断到死亡的平均生存期为15年[1]。帕金森病的病因和发病机制十分复杂,至今仍未彻底明确。
作者 魏其林 王军
出处 《交通医学》 2012年第2期124-126,129,共4页 Medical Journal of Communications
基金 国家"863"重大课题资助项目(2006AA02A128) 江苏省自然科学基金创新攀登项目(BK2008010)
  • 相关文献

参考文献21

  • 1Katzenschlager R, Head J, Schraq A, et al. Fourteen-year final report of the randomized three initial treatments in PD 474-480. PDRG-UK trial comparing [J]. Neurology, 2008, 71 (7):.
  • 2Alves G, Wentzel-Larsen T, Aarsland D, et al. Progression of motor impairment and disability in Parkinson disease: a pop- ulation-based study[J]. Neurology,2005,65(9):1436-1441.
  • 3Harrison MB, Wylie SA, Frysinger RC, et al. UPDRS activity of daily living score as a marker of Parkinson's disease pro- gression[J]. Mov Disord,2009,24(3):224-230.
  • 4Goetz CG, Stebbins GT, Blasucci LM. Differential progres- sion of motor impairment in levodopa-treated Parkinson's disease[J]. Mov Disord,2000,15(3 ):479-484.
  • 5Jankovic J, Kapadia AS. Functional decline in Parkinson dis- ease[J]. Arch Neurol,2001,58(10):1611-1615.
  • 6Olanow CW, Rascol O, Hauser R, et al. A double-blind, de- layed-start trial of rasagiline in Parkinson's disease [J]. N Engl J Med,2009,361 ( 11 ): 1268-1278.
  • 7Fahn S, Oakes D, Shoulson I, et al. Levodopa and the pro- gression of Parkinson's disease[J].N Engl J Med,2004,351 (24):2498-2508.
  • 8Louis ED, Tang MX, Cote L, et al. Progression of parkinsoni- an signs in Parkinson disease[J]. Arch Neurol,1999,56(2): 334-337.
  • 9Jonathan RE, Sarah LM, Caroline HW,et al.The natural his- tory of treated Parkinson' s disease in an incident, communi- ty based cohort[J]. Neurol Neurosurg Psychiatry,2011,82(10)- 1112-1118.
  • 10Clissold BG, McColl CD, Reardon KR, et al. Longitudinal study of the motor response to levodopa in Parkinson's dis- ease[J]. Mov Disord, 2006,21 ( 12):2116-2121.

同被引文献15

  • 1倪敬年,时晶,田金洲,王永炎.路易体痴呆与帕金森病痴呆的临床诊断和治疗[J].中国医学前沿杂志(电子版),2012,4(10):7-12. 被引量:10
  • 2Aarsland D, Andersen K, Larsen JP, et al. Prevalence and charac- teristics of dementia in Parkinson disease:an 8 - year prospective study I J 1. Arch Neurol,2003,60 (3) : 387-392.
  • 3Kehagia AA, Barker RA, Robbins Tw. Neur0psyehological and clinical heterogeneity of cognitive impairment and dementia in- patients with Parkinson' s disease [J]. Lancet Neurol, 2010,9 ( 12 ) : 1200-1213.
  • 4Beyer MK, Larsen JP, Aarsland D. Gray matter atrophy in Parkin- son disease with dementia and dementia with Lewy bodies[ J]. Neurology,2007,69 ( 8 ) :747-754.
  • 5Xu J, Gong DD, Man CF, et al. Parkinson s disease and risk of m0ftality : meta - analysis and systematic review [ J ]. Acta Neu- ral Scand,2014,129(2) :71-79.
  • 6Vossius C, Larsen JP, Janvin C, et al. The economic impact of cognitive impairment in Parkinson s disease [ J ]. Mov Disord, 2011,26(8) :1541-1544.
  • 7Martinez Martin P, Falup Pecurariu C, Rodriguez Blazquez C, et al. Dementia associated with Parkinsan s disease: applying the Move -ment Disorder Society Task Force criteria[ J]. Parkinson- ism RelatDisord ,2011,17 ( 8 ) :621-624.
  • 8Dahymple - Alford JC, Livingston L, MaeAskill MR, et al. Char- acteri - zing mild cognitive impairment in Parkinson s disease[J].Mov Disord ,2011,26 (4) :629-636.
  • 9Gonzdlez - Aramburu I, Sdnchez - Juan P, Sierra M. et al. Serum uricacid and risk of dementia in Parkinson s disease [ J ]. Parkin- sonism Relat Disord ,2014,20 (6) :637-639.
  • 10俱西驰,屈秋民,王伟,答嵘,罗国刚,赵婷婷,宋文峰.血清尿酸水平与帕金森病认知功能障碍的关系[J].南京医科大学学报(自然科学版),2013,33(1):59-61. 被引量:13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部